Low penetrance genetic susceptibility to kidney cancer

BJU International

Volumn 98, Issue 4, 2006, Pages 735-738

  Thibault, Frédéric ^a   Cancel Tassin, Géraldine ^a   Cussenot, Olivier ^a,b  

^a Service d'Urologie   (France)

^b HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ANTINEOPLASTIC AGENT; BREAST CANCER RESISTANCE PROTEIN; CARCINOGEN; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; CYTOKINE; ESTROGEN; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; GLYCOPROTEIN P; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERSTITIAL COLLAGENASE; MULTIDRUG RESISTANCE PROTEIN 2; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA; VITAMIN D RECEPTOR; VON HIPPEL LINDAU PROTEIN;

ANGIOGENESIS; CANCER GROWTH; CANCER RISK; CANCER STAGING; CATALYSIS; GENE DELETION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HYPOXIA; INCIDENCE; INFECTION; KIDNEY CANCER; PRIORITY JOURNAL; PROTEIN FOLDING; SHORT SURVEY;

CARCINOGENS; CARCINOMA, RENAL CELL; CYTOKINES; ESTROGENS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY NEOPLASMS; MALE; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; PENETRANCE;

EID: 33748540426     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06351.x     Document Type: Short Survey

References (16)

1. Gallou C, Longuemaux S, Delomenie C et al. Association of GSTT1 non-null and NAT1 slow/rapid genotypes with von Hippel-Lindau tumour suppressor gene transversions in sporadic renal cell carcinoma. Pharmacogenetics 2001; 11: 521-35
2. Gudbjartsson T, Jonasdottir TJ, Thoroddsen A et al. A population-based familial aggregation analysis indicates genetic contribution in a majority of renal cell carcinomas. Int J Cancer 2002; 100: 476-9
3. Sasaki M, Tanaka Y, Okino ST et al. Polymorphisms of the CYP1B1 gene as risk factors for human renal cell cancer. Clin Cancer Res 2004; 10: 2015-9
4. Sweeney C, Farrow DC, Schwartz SM, Eaton DL, Checkoway H, Vaughan TL. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study. Cancer Epidemiol Biomarkers Prev 2000; 9: 449-54
5. Buzio L, De Palma G, Mozzoni P et al. Glutathione S-transferases M1-1 and T1-1 as risk modifiers for renal cell cancer associated with occupational exposure to chemicals. Occup Environ Med 2003; 60: 789-93
6. Longuemaux S, Delomenie C, Gallou C et al. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Cancer Res 1999; 59: 2903-8
7. Hirata H, Naito K, Yoshihiro S, Matsuyama H, Suehiro Y, Hinoda Y. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma. Int J Cancer 2003; 106: 372-4
8. Hirata H, Okayama N, Naito K et al. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma. Carcinogenesis 2004; 25: 2379-84
9. Siegsmund M, Brinkmann U, Schaffeler E et al. Association of the P-glycoprotein transporter MDR1 (C3435T) polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol 2002; 13: 1847-54
10. Korenaga Y, Naito K, Okayama N et al. Association of the BCRP C421A polymorphism with nonpapillary renal cell carcinoma. Int J Cancer 2005; 117: 431-4
11. Basturk B, Yavascaoglu I, Vuruskan H, Goral G, Oktay B, Oral HB. Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma. Cytokine 2005; 30: 41-5
12. Nakamura E, Megumi Y, Kobayashi T et al. Genetic polymorphisms of the interleukin-4 receptor alpha gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population. Clin Cancer Res 2002; 8: 2620-5
13. Ollerenshaw M, Page T, Hammonds J, Demaine A. Polymorphisms in the hypoxia inducible factor-1alpha gene (HIF1A) are associated with the renal cell carcinoma phenotype. Cancer Genet Cytogenet 2004; 153: 122-6
14. Tanaka Y, Sasaki M, Kaneuchi M, Fujimoto S, Dahiya R. Estrogen receptor alpha polymorphisms and renal cell carcinoma - a possible risk. Mol Cell Endocrinol 2003; 202: 109-16
15. Tanaka Y, Sasaki M, Kaneuchi M, Fujimoto S, Dahiya R. Single nucleotide polymorphisms of estrogen receptor alpha in human renal cell carcinoma. Biochem Biophys Res Commun 2002; 296: 1200-6
16. Ikuyama T, Hamasaki T, Inatomi H, Katoh T, Muratani T, Matsumoto T. Association of vitamin D receptor gene polymorphism with renal cell carcinoma in Japanese. Endocr J 2002; 49: 433-8